Author:
Hidayat Muh. Taufik,Fitrayani Nurul,Alik Samma Abigael,Anggriani A.,Permana Andi Dian
Funder
Kementerian Riset dan Teknologi Republik Indonesia
Reference43 articles.
1. Efavirenz: history, development and future;Costa;Biomolecules,2022
2. World Health Organization, Guidelines hiv prevention, testing, treatment, service delivery and monitoring:, no. July. 2021.
3. Characterization, in vitro dissolution, and pharmacokinetics of different batches of efavirenz raw materials;Bedor;Drug Dev. Ind. Pharm.,2021
4. G. Ajibola et al., “Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy,” South. Afr. J. HIV Med., vol. 21, no. 1, Jan. 2020, doi: 10.4102/sajhivmed.v21i1.1023.
5. Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, northeast, Ethiopia: a case–control study;Meshesha;BMJ Open,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献